NeuroMetrix Inc (NURO) Stock
NURO is no longer traded. NeuroMetrix was delisted from the Nasdaq in May 2025.
Prices on this page are historical; the last trade was May 1, 2025 at $4.58.
NeuroMetrix stock price history
NURO final trading statistics
- Final close
- $4.58
- Final trading day
- May 1, 2025
- Market cap at delisting
- $9.43M
- Shares outstanding
- 2.06M
- Final 52-week range
- $2.66 – $4.73
- Avg. volume (final 3 mo.)
- 7,379
- All-time high (split-adj.)
- $1000000.00 · Sep 2004
- All-time low (split-adj.)
- $2.79 · Aug 2024
- Return since IPO
- -100.0%
- Beta
- 1.83
- Book value / share
- $6.98
- Price / book
- 0.66
NeuroMetrix annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $3.03M | -$7.8M | — |
| FY2023 | $5.90M | -$6.5M | -$1.68 |
| FY2022 | $8.26M | -$4.4M | -$1.61 |
| FY2021 | $8.25M | -$2.2M | -$2.41 |
| FY2020 | $7.38M | -$2.0M | -$0.89 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About NeuroMetrix Inc
NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing and sale of medical devices. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; and Quell, a wearable device for symptomatic relief and management of chronic pain. The company offers its products to managed endocrinologists, podiatrists, primary care physicians, and other clinicians at the point-of care to objectively detect, stage, and monitor peripheral neuropathies. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.
NeuroMetrix stock FAQ
What happened to NeuroMetrix stock?
NeuroMetrix stock was delisted from the Nasdaq. Its final close was $4.58 on May 1, 2025.
Is NURO stock still trading?
No. NURO was delisted from the Nasdaq in May 2025 and no longer trades on a U.S. exchange.
What was the last price of NURO stock?
NURO closed at $4.58 on its final trading day, May 1, 2025, for a market value of about $9.43M.
What were NeuroMetrix's revenue and earnings in its last full fiscal year?
NeuroMetrix reported revenue of $3.03M and net income of -$7.8M in fiscal 2024, its last full year as a public company.
When did NeuroMetrix go public?
NeuroMetrix Inc stock began trading on January 2, 2001.